Meeting
2021 Genitourinary Cancers Symposium
Evaluating financial burdens of oral hormonal therapies for patients with prostate cancer.
Authors
Eric B Schwartz
Michigan Medicine, Ann Arbor, MI
Eric B Schwartz , Angelina Jeong , Andrea Roman , Rachel McDevitt , Elyssa Henry , Megan Veresh Caram
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 70)
DOI
10.1200/JCO.2021.39.6_suppl.70
Abstract #
70
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Associations between costs of oral hormonal therapies for prostate cancer, financial assistance mechanisms, and time on treatment.
First Author: Eric B Schwartz
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient perceptions regarding the process of obtaining oral prostate cancer medications.
First Author: Eric B Schwartz
Poster
2020 Genitourinary Cancers Symposium
Financial hardship among Medicare beneficiaries prescribed oral targeted therapies for advanced prostate cancer.
First Author: Megan Veresh Caram
Poster
2019 ASCO Quality Care Symposium
Impact of in-house specialty pharmacy on access to novel androgen axis inhibitors in men with advanced prostate cancer.
First Author: Nathan Handley